文献速递贫血与红细胞疾病

设计转录激活样效应器高水平重新激活胎儿珠蛋白

High level of fetal-globin reactivation by designed transcriptional activator-like effector.
PubMed 文献 · Blood Adv · 2020-01-01

研究设计靶向Gγ和Aγ珠蛋白启动子的转录激活样效应器(TALE),融合Ldb1二聚化结构域并装入慢病毒载体,经密码子优化后在人脐血来源红系祖细胞(HUDEP-2)中测试。14个TALE中5个使γ珠蛋白mRNA水平显著增加超过70倍,β珠蛋白mRNA减少超过50%,高效液相色谱显示胎儿珠蛋白超过30%(对照2%)。在CD34红系分化第19天,2个TALE使胎儿珠蛋白mRNA增加超过40倍,占总珠蛋白蛋白高达70%。

要点

  • 5/14 TALE在HUDEP-2细胞中使γ珠蛋白mRNA增加超过70倍
  • 胎儿珠蛋白蛋白水平超过30%,对照为2%
  • CD34分化第19天2个TALE使胎儿珠蛋白mRNA增加超过40倍,蛋白达70%

核心结论

  • 设计的TALE可高水平重新激活胎儿珠蛋白表达,具有临床转化潜力。

研究设计与样本

  • 设计靶向Gγ和Aγ珠蛋白启动子的TALE,融合Ldb1二聚化结构域并装入慢病毒载体,经密码子优化后在人脐血来源红系祖细胞(HUDEP-2)中测试。

主要发现

  • 14个TALE中5个在HUDEP-2细胞中使γ珠蛋白mRNA水平显著增加超过70倍。
  • β珠蛋白mRNA减少超过50%。
  • 高效液相色谱显示TALE诱导细胞中胎儿珠蛋白超过30%,对照为2%。
  • 在CD34红系分化第19天,2个TALE使胎儿珠蛋白mRNA增加超过40倍,占总珠蛋白蛋白高达70%。

关键数值与推荐

  • 含β珠蛋白基因启动子与基因座控制区(LCR)增强子的组合在CD34红系分化中TALE表达最高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The fetal-to-adult hemoglobin switch has been a focus of a long-standing effort to potentially treat sickle cell disease and β thalassemia by induction of fetal hemoglobin. In a continuation of this effort, we designed specific transcriptional activator-like effectors (TALEs) to target both the Gγ and Aγ-globin promoters. We fused the TALEs to a LIM domain binding protein (Ldb1) dimerization domain, followed by a T2A green fluorescent protein (GFP) cassette, which were assembled into a lentiviral vector. To prevent deletions caused by the repeats of TALEs during the lentivirus packing process, we changed the TALE encoding DNA by codon optimization. Intriguingly, 5 of 14 TALEs showed forced reactivation of fetal-globin expression in human umbilical cord blood-derived erythroid progenitor (HUDEP-2) cells, with a significant increase in the γ-globin mRNA level by more than 70-fold. We also observed a more than 50% reduction of β-globin mRNA. High-performance liquid chromatography analysis revealed more than 30% fetal globin in TALE-induced cells compared with the control of 2%. Among several promoters studied, the β-globin gene promoter with the locus control region (LCR) enhancer showed the highest TALE expression during CD34 erythroid differentiation. At day 19 of differentiation, 2 TALEs increased fetal-globin expression more than 40-fold in the mRNA level and up to 70% of the total globin protein. These TALEs have potential for clinical translation.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Zhan J, Irudayam MJ, Nakamura Y, et al. High level of fetal-globin reactivation by designed transcriptional activator-like effector. Blood Adv. 2020. PMID: 32084259. doi:10.1182/bloodadvances.2019000482

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。